drugset / Trial / NCT02005653

Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti Infection

NCT02005653

Phase 4 Completed 146 enrolled Indian Council of Medical Research
RandomizedParallel-groupDouble-blindTreatment

Summary

Diethylcarbamazine (DEC) essentially a micro-filaricidal drug is given for 12 days as standard treatment for the clearance of W. bancrofti infection. It takes about one year for the individuals to completely clear the microfilaria from the blood. It takes another two to four years to clear the antigen. The aim of the present study is to shorten the time taken for clearing the Mf and antigen from the blood either by co-administration or sequential administration of a macrofilaricidal drug, Albendazole or doxycycline. This study is a randomized, double blind, controlled clinical trial to study the efficacy of these drug combinations in complete clearance the Mf and antigen from the blood in shorter span of 180 days and 365 days respectively.

Timeline

Start
2009-02
Primary completion
2011-09
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Albendazole Small molecule 400 mg Oral
Subject Diethylcarbamazine Small molecule 300 mg Oral
Subject Doxycycline Small molecule 100 mg Oral

Indications